These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24318486)

  • 41. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
    Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC
    J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resistance at virological failure using boosted protease inhibitors versus nonnucleoside reverse transcriptase inhibitors as first-line antiretroviral therapy--implications for sustained efficacy of ART in resource-limited settings.
    Hill A; McBride A; Sawyer AW; Clumeck N; Gupta RK
    J Infect Dis; 2013 Jun; 207 Suppl 2():S78-84. PubMed ID: 23687293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Persistence of earlier HIV-1 drug resistance mutations at new treatment failure.
    Svedhem V; Lindkvist A; Lidman K; Sönnerborg A
    J Med Virol; 2002 Dec; 68(4):473-8. PubMed ID: 12376953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short communication. Antiretroviral drug resistance among drug-naive HIV-1-infected individuals in Djibouti (Horn of Africa).
    Maslin J; Rogier C; Caron M; Grandadam M; Koeck JL; Nicand E
    Antivir Ther; 2005; 10(7):855-9. PubMed ID: 16312182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiretroviral resistance and genetic diversity of human immunodeficiency virus type 1 isolates from the Federal District, Central Brazil.
    Cerqueira DM; Amorim RM; Silva RR; Camara GN; Brígido MM; Martins CR
    Mem Inst Oswaldo Cruz; 2004 Dec; 99(8):877-82. PubMed ID: 15761606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of HIV type 1 antiretroviral drug resistance mutations in Vietnam: a multicenter study.
    Dean J; Ta Thi TH; Dunford L; Carr MJ; Nguyen LT; Coughlan S; Connell J; Nguyen HT; Hall WW; Nguyen Thi LA
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):797-801. PubMed ID: 21366425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of HIV type 1 genotypes and drug resistance mutations among drug-naive HIV type 1-infected patients in Northern Vietnam.
    Phan TT; Ishizaki A; Phung DC; Bi X; Oka S; Ichimura H
    AIDS Res Hum Retroviruses; 2010 Feb; 26(2):233-5. PubMed ID: 20156106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiretroviral treatment outcome in HIV-1-infected patients routinely followed up in capital cities and remote areas of Senegal, Mali and Guinea-Conakry.
    Diouara AA; Ndiaye HD; Guindo I; Bangoura N; Cissé M; Edmond T; Bougoudogo F; Mboup S; Peeters M; Ayouba A; Kane NC
    J Int AIDS Soc; 2014; 17(1):19315. PubMed ID: 25527333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
    Teto G; Tagny CT; Mbanya D; Fonsah JY; Fokam J; Nchindap E; Kenmogne L; Njamnshi AK; Kanmogne GD
    Sci Rep; 2017 Oct; 7(1):14136. PubMed ID: 29074854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular characterization of HIV type 1 in Brazzaville, Republic of Congo, and first data on resistance to antiretroviral drugs.
    Pircher M; Diafouka M; Papuchon J; Recordon-Pinson P; Mahambou DN; Akolbout M; Simon B; Fleury H
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1798-802. PubMed ID: 22697883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines.
    Fokam J; Takou D; Santoro MM; Akonie HZ; Kouanfack C; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):329-33. PubMed ID: 26602836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure.
    Mohamed S; Penaranda G; Gonzalez D; Camus C; Khiri H; Boulmé R; Sayada C; Philibert P; Olive D; Halfon P
    AIDS; 2014 Jun; 28(9):1315-24. PubMed ID: 24698843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde.
    Gonçalves P; Barreto J; Santos M; Leal S; Marcelino J; Abecasis A; Palladino C; Taveira N
    AIDS; 2024 Jul; 38(8):1101-1110. PubMed ID: 38349224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco.
    El Annaz H; Recordon-Pinson P; Tagajdid R; Doblali T; Belefquih B; Oumakhir S; Sedrati O; Mrani S; Fleury H
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):944-8. PubMed ID: 21919803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sustained virological failure in Cameroonese patient infected by HIV-1 group N evidenced by sequence-based genotyping assay.
    Péré H; Roques P; Talla F; Meillo H; Charpentier C; Bélec L
    AIDS; 2015 Jun; 29(10):1267-9. PubMed ID: 26035326
    [No Abstract]   [Full Text] [Related]  

  • 56. Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M.
    Depatureaux A; Charpentier C; Leoz M; Unal G; Damond F; Kfutwah A; Vessière A; Simon F; Plantier JC
    J Acquir Immune Defic Syndr; 2011 Feb; 56(2):139-45. PubMed ID: 21233638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
    Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A
    PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic characterization of HIV type 1 among patients with suspected immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy in Kenya.
    Lihana RW; Khamadi SA; Lubano K; Mwangi J; Kinyua JG; Okoth VO; Lagat NJ; Okoth FA; Songok EM; Makokha EP
    AIDS Res Hum Retroviruses; 2010 Jul; 26(7):833-8. PubMed ID: 20624074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of amplification refractory mutation system PCR assay as a simple and effective tool to detect HIV-1 drug resistance mutations.
    Nanfack AJ; Agyingi L; Noubiap JJ; Ngai JN; Colizzi V; Nyambi PN
    J Clin Microbiol; 2015 May; 53(5):1662-71. PubMed ID: 25788547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy.
    Nishizawa M; Matsuda M; Hattori J; Shiino T; Matano T; Heneine W; Johnson JA; Sugiura W
    PLoS One; 2015; 10(9):e0135941. PubMed ID: 26360259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.